Omicron-specific Covid vaccine for India in 6 months, expects Adar Poonawalla
New Delhi: Serum Institute of India’s Covid vaccine, Covovax is now approved for administration to children, CEO Adar Poonwalla announced on Tuesday. According to the reports, children can get the vaccine at private centres with a provision for it being made on the CoWIN portal.
Earlier today, Poonawalla took to Twitter and wrote, “Covovax (@Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > 90%. This is in line with Shri @narendramodi Ji’s vision of providing yet another vaccine to protect our children.”
According to the reports, children can get the vaccine at private centres with a provision for it being made on the CoWIN portal.
Covovax (@Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > 90%. This is in line with Shri @narendramodi Ji’s vision of providing yet another vaccine to protect our children. pic.twitter.com/QUm7sZyOfi
To recall, Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, had recently written to the Union Health Ministry, requesting to include Covovax in the vaccination campaign for children in the age group of 12-17 years. Now children in the age group of 12-17 years can get the Covovax vaccine at a private centre.
Currently, children aged 12 to 14 years are vaccinated with Biological E’s intramuscular vaccine Corbevax, while those in the 15-18 age group are being administered Bharat Biotech’s Covaxin at government vaccination centres.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts Cookies Policy.